Your browser doesn't support javascript.
loading
Progress in the treatment of diabetic peripheral neuropathy.
Yang, Ke; Wang, Yue; Li, Yi-Wei; Chen, Yi-Gong; Xing, Na; Lin, Han-Bin; Zhou, Ping; Yu, Xiao-Ping.
Affiliation
  • Yang K; Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine, College of Life Science, China Jiliang University, Hangzhou 310018, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
  • Wang Y; Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine, College of Life Science, China Jiliang University, Hangzhou 310018, China.
  • Li YW; Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine, College of Life Science, China Jiliang University, Hangzhou 310018, China.
  • Chen YG; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, No. 18, Chaowang Road, Xiacheng District, Hangzhou, Zhejiang 310014, China.
  • Xing N; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528400, Guangdong, China.
  • Lin HB; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528400, Guangdong, China. Electronic address: linhanbin@simm.ac.cn.
  • Zhou P; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, No. 49, Huayuan North Road, Haidian District, Beijing100191, China. Electronic address: zhoup0520@163.com.
  • Yu XP; Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine, College of Life Science, China Jiliang University, Hangzhou 310018, China. Electronic address: yxp@cjlu.edu.cn.
Biomed Pharmacother ; 148: 112717, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35193039
ABSTRACT
Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes. Symptoms of DPN mainly include spontaneous intractable pain that is diffuse and continuous and can last from several weeks to several months. DPN is associated with a high mortality rate and poor prognosis. Its pathogenesis is not fully understood, and clinical treatment is focused on relieving its clinical symptoms, as well as improving blood sugar control and cardiovascular risk factors. DPN and its clinically effective treatments need to be studied. This study discusses the treatment methods and pathogenesis of DPN, summarizes the related research progress, and attempts to provide a reference for DPN research.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Neuropathies Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Neuropathies Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2022 Document type: Article Affiliation country: